Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial
Articolo
Data di Pubblicazione:
2025
Citazione:
Aspirin and Hemocompatibility After LVAD
Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary
Analysis From the ARIES-HM3 Randomized Clinical Trial / Gustafsson, F., Uriel, N., Netuka, I., Katz, J.n., Pagani, F.d., Connors, J.m., Jorde, U.p., Zimpfer, D., Pya, Y., Conway, J., Anyanwu, A., Scandroglio, A., Sulemanjee, N., Atluri, P., Keebler, M., Selzman, C.h., Alexis, J.d., Hayward, C., Henderson, J., Dirckx, N., et al.. - In: JAMA CARDIOLOGY. - ISSN 2380-6583. - 10:3(2025), pp. 235-242. [10.1001/jamacardio.2024.4849]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Gustafsson, F; Uriel, N; Netuka, I; Katz, Jn; Pagani, Fd; Connors, Jm; Jorde, Up; Zimpfer, D; Pya, Y; Conway, J; Anyanwu, A; Scandroglio, A; Sulemanjee, N; Atluri, P; Keebler, M; Selzman, Ch; Alexis, Jd; Hayward, C; Henderson, J; Dirckx, N; Gazzola, C; Mehra, Mr; Aries, Investigators.
Link alla scheda completa:
Pubblicato in: